Kuzur ME, Albain KS, Huntington MO, et al. A phase II trial of docetaxel and Herceptin in metastatic breast cancer patients overexpressing HER-2. Proc Am Soc Clin Oncol 2000;19:131a. Leyland-Jones B, Hemmings F, Arnold A, et al. Pharmacokinetics of Herceptin administered with paclitaxel every three weeks. Breast Cancer Res Treat 2000; 64:124.